Advances in Urology / 2022 / Article / Tab 2 / Research Article
Role and Utility of Mixed Reality Technology in Laparoscopic Partial Nephrectomy: Outcomes of a Prospective RCT Using an Indigenously Developed Software Table 2 Intra and postoperative variables.
Control Experimental valueHb after surgery (g/l), mean (SD) 120 (17.1) 125 (14.6) 0.28 Operative time (min), mean (SD) 106 (28.4) 95 (24) 0.15 Time for renal pedicle exposure (min), mean (SD) 14.08 (5.4) 8.22 (2.76) <0.001 Time from renal pedicle to tumor, min, mean (SD) 13.54 (5.99) 7.52 (3.36) <0.001 Hemorrhage volume (ml), median (IQR) 150 (200) 100 (150) 0.11 Creatinine postoperative (mcmol/l), median (IQR) 101 (33.8) 88 (35) 0.35 RA clamping, no. (%) No 2 (8.3) 6 (26.1) 0.11 Yes 22 (91.7) 17 (73.9) Global ischemia time (min), mean (SD) 15.1 (7.73) 17 (7.33) 0.38 Conversion to nephrectomy, no. (%) No 22 (91.7) 23 (100) 0.16 Yes 2 (8.3) 0 (0) Clavien–Dindo score <3, no. (%) No 22 (91.7) 22 (95.7) 0.58 Yes 2 (8.3) 1 (4.3) Clavien–Dindo ≥3, no. (%) No 23 (95.8) 23 (100) 0.32 Yes 1 (4.2) 0 (0) Histopathological findings, no. (%) RO 1 (4.2) 2 (8.7) 0.78 PRCC 1 (4.2) 2 (8.7) ccRCC 20 (83.3) 18 (78.3) Others 2 (8.3) 1 (4.3) Surgical margin, no. (%) Positive 2 (8.3) 0 (0) 0.49 Negative 22 (91.7) 23 (100) GFR postoperative (ml/min), median (IQR) 65.6 (62.9) 85.2 (48.4) 0.47 US tumor control, no. (%) — 23 (100) —
Renal oncocytoma;
papillary renal cell carcinoma;
clear cell renal cell carcinoma.